Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Patients with need of platelet transfusion for any reason will participate in this study.
Directly before the start of infusion and one hour after the end of platelet transfusion
blood samples will be drawn and treated with different concentrations of Fibrinogen (a blood
clotting factor) in-vitro. Blood samples with and without Fibrinogen/platelet transfusion
will be compared. The study hypothesis is that treatment with Fibrinogen results in a better
stabilisation of blood coagulation.